Skip to content
← Back to this collection

PUBLICATIONS · 20368567

BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
J Clin Oncol
Publication date
2010 May 1
First author
van Oers MH

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Oct 20;28(30):e613; author reply e614. doi: 10.1200/JCO.2010.30.7280.
    note
    Source null
    related pmid
    20713852
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2011 Apr 10;29(11):e318; author reply e319. doi: 10.1200/JCO.2010.33.9622.
    note
    Source null
    related pmid
    21383300
    relationship
    Comment in

Authors and identifiers

  1. name
    van Oers MH
    type
    Author
  2. name
    Tönnissen E
    type
    Author
  3. name
    Van Glabbeke M
    type
    Author
  4. name
    Giurgea L
    type
    Author
  5. name
    Jansen JH
    type
    Author
  6. name
    Klasa R
    type
    Author
  7. name
    Marcus RE
    type
    Author
  8. name
    Wolf M
    type
    Author
  9. name
    Kimby E
    type
    Author
  10. name
    Vranovsky A
    type
    Author
  11. name
    Holte H
    type
    Author
  12. name
    Hagenbeek A
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    van Oers MH
    type
    Author
  2. name
    Tönnissen E
    type
    Author
  3. name
    Van Glabbeke M
    type
    Author
  4. name
    Giurgea L
    type
    Author
  5. name
    Jansen JH
    type
    Author
  6. name
    Klasa R
    type
    Author
  7. name
    Marcus RE
    type
    Author
  8. name
    Wolf M
    type
    Author
  9. name
    Kimby E
    type
    Author
  10. name
    Vranovsky A
    type
    Author
  11. name
    Holte H
    type
    Author
  12. name
    Hagenbeek A
    type
    Author
bibliography ids
  1. nci-bib-9ff9ff24a8640207a57270af
book metadata
content sha256
9b53b299a343406df805eb16df6a2d29c61874ef496c1ca4b0f4099399548a67
document type
citation
dois
  1. 10.1200/JCO.2009.25.0852
electronic publication date
display
2010 Apr 5
precision
day
year
2010
evidence scope
bibliographic_metadata_only
id
pubmed:20368567
immutable id
pubmed:20368567@9b53b299a343406df805eb16df6a2d29c61874ef496c1ca4b0f4099399548a67
journal
abbreviation
J Clin Oncol
issn electronic
1527-7755
issn print
0732-183X
issue
13
name
Journal of clinical oncology : official journal of the American Society of Clinical Oncology
nlm unique id
8309333
pages
2246-52
volume
28
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    J Clin Oncol. 2010 Oct 20;28(30):e613; author reply e614. doi: 10.1200/JCO.2010.30.7280.
    note
    Source null
    related pmid
    20713852
    relationship
    Comment in
  2. citation
    J Clin Oncol. 2011 Apr 10;29(11):e318; author reply e319. doi: 10.1200/JCO.2010.33.9622.
    note
    Source null
    related pmid
    21383300
    relationship
    Comment in
outcomes validated
false
pmid
20368567
provenance
batch id
bce21fa556c206e375c2
provider
NCBI PubMed ESummary
record sha256
3187f0e4200a89a4319100b278130e5b734bdd54073db0e358ede2ba0c12cba7
response sha256
280642fcc56e65c443f5ee9e69c6371de9e91c70665c7390bba25595a34da323
retrieved at
2026-09-09T23:46:33.526275+00:00
publication date
display
2010 May 1
precision
day
year
2010
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Multicenter Study
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/20368567/
title
BCL-2/IgH polymerase chain reaction status at the end of induction treatment is not predictive for progression-free survival in relapsed/resistant follicular lymphoma: results of a prospective randomized EORTC 20981 phase III intergroup study.

Preserved source evidence · Independent clinical review pending · Not medical advice